Greyson International, Inc.
Greyson International, Inc. GYSN Peers
See (GYSN) competitors and their performances in Stock Market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GYSN | $0.00 | +0.00% | 14K | N/A | N/A | N/A |
| LRLCY | $84.37 | -0.04% | 225.4B | 31.13 | $2.71 | +1.88% |
| LRLCF | $417.30 | -1.81% | 223B | 30.87 | $13.52 | +1.90% |
| UNLYF | $63.36 | N/A | 158.3B | 24.37 | $2.60 | +3.05% |
| RBGLY | $13.44 | +0.22% | 45.8B | 24.44 | $0.55 | +3.89% |
| RBGPF | $65.05 | N/A | 44.3B | 23.83 | $2.73 | +4.03% |
| HENOY | $19.89 | +0.15% | 31.3B | 14.73 | $1.35 | +2.55% |
| HENKY | $17.88 | +0.06% | 31.3B | 13.24 | $1.35 | +2.80% |
| HELKF | $71.33 | +0.01% | 31.2B | 13.16 | $5.42 | +2.82% |
| HENOF | $79.86 | N/A | 31B | 14.76 | $5.41 | +2.55% |
Stock Comparison
GYSN vs LRLCY Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, LRLCY has a market cap of 225.4B. Regarding current trading prices, GYSN is priced at $0.00, while LRLCY trades at $84.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas LRLCY's P/E ratio is 31.13. In terms of profitability, GYSN's ROE is +0.14%, compared to LRLCY's ROE of +0.21%. Regarding short-term risk, GYSN is less volatile compared to LRLCY. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs LRLCF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, LRLCF has a market cap of 223B. Regarding current trading prices, GYSN is priced at $0.00, while LRLCF trades at $417.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas LRLCF's P/E ratio is 30.87. In terms of profitability, GYSN's ROE is +0.14%, compared to LRLCF's ROE of +0.21%. Regarding short-term risk, GYSN is less volatile compared to LRLCF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs UNLYF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, UNLYF has a market cap of 158.3B. Regarding current trading prices, GYSN is priced at $0.00, while UNLYF trades at $63.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas UNLYF's P/E ratio is 24.37. In terms of profitability, GYSN's ROE is +0.14%, compared to UNLYF's ROE of +0.33%. Regarding short-term risk, GYSN is less volatile compared to UNLYF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs RBGLY Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, RBGLY has a market cap of 45.8B. Regarding current trading prices, GYSN is priced at $0.00, while RBGLY trades at $13.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas RBGLY's P/E ratio is 24.44. In terms of profitability, GYSN's ROE is +0.14%, compared to RBGLY's ROE of +0.21%. Regarding short-term risk, GYSN is less volatile compared to RBGLY. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs RBGPF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, RBGPF has a market cap of 44.3B. Regarding current trading prices, GYSN is priced at $0.00, while RBGPF trades at $65.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas RBGPF's P/E ratio is 23.83. In terms of profitability, GYSN's ROE is +0.14%, compared to RBGPF's ROE of +0.21%. Regarding short-term risk, GYSN is less volatile compared to RBGPF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs HENOY Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, HENOY has a market cap of 31.3B. Regarding current trading prices, GYSN is priced at $0.00, while HENOY trades at $19.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas HENOY's P/E ratio is 14.73. In terms of profitability, GYSN's ROE is +0.14%, compared to HENOY's ROE of +0.08%. Regarding short-term risk, GYSN is less volatile compared to HENOY. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs HENKY Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, HENKY has a market cap of 31.3B. Regarding current trading prices, GYSN is priced at $0.00, while HENKY trades at $17.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas HENKY's P/E ratio is 13.24. In terms of profitability, GYSN's ROE is +0.14%, compared to HENKY's ROE of +0.10%. Regarding short-term risk, GYSN is less volatile compared to HENKY. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs HELKF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, HELKF has a market cap of 31.2B. Regarding current trading prices, GYSN is priced at $0.00, while HELKF trades at $71.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas HELKF's P/E ratio is 13.16. In terms of profitability, GYSN's ROE is +0.14%, compared to HELKF's ROE of +0.08%. Regarding short-term risk, GYSN is less volatile compared to HELKF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs HENOF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, HENOF has a market cap of 31B. Regarding current trading prices, GYSN is priced at $0.00, while HENOF trades at $79.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas HENOF's P/E ratio is 14.76. In terms of profitability, GYSN's ROE is +0.14%, compared to HENOF's ROE of +0.08%. Regarding short-term risk, GYSN is less volatile compared to HENOF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs BDRFF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, BDRFF has a market cap of 30.9B. Regarding current trading prices, GYSN is priced at $0.00, while BDRFF trades at $138.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas BDRFF's P/E ratio is 30.23. In terms of profitability, GYSN's ROE is +0.14%, compared to BDRFF's ROE of +0.09%. Regarding short-term risk, GYSN is less volatile compared to BDRFF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs BDRFY Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, BDRFY has a market cap of 30.6B. Regarding current trading prices, GYSN is priced at $0.00, while BDRFY trades at $27.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas BDRFY's P/E ratio is 29.47. In terms of profitability, GYSN's ROE is +0.14%, compared to BDRFY's ROE of +0.09%. Regarding short-term risk, GYSN is less volatile compared to BDRFY. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs KAOOY Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, KAOOY has a market cap of 20.5B. Regarding current trading prices, GYSN is priced at $0.00, while KAOOY trades at $8.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas KAOOY's P/E ratio is 25.97. In terms of profitability, GYSN's ROE is +0.14%, compared to KAOOY's ROE of +0.05%. Regarding short-term risk, GYSN is less volatile compared to KAOOY. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs KAOCF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, KAOCF has a market cap of 19.2B. Regarding current trading prices, GYSN is priced at $0.00, while KAOCF trades at $41.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas KAOCF's P/E ratio is 24.18. In terms of profitability, GYSN's ROE is +0.14%, compared to KAOCF's ROE of +0.05%. Regarding short-term risk, GYSN is less volatile compared to KAOCF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs ETTYF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, ETTYF has a market cap of 19.2B. Regarding current trading prices, GYSN is priced at $0.00, while ETTYF trades at $27.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas ETTYF's P/E ratio is 14.71. In terms of profitability, GYSN's ROE is +0.14%, compared to ETTYF's ROE of +0.15%. Regarding short-term risk, GYSN is less volatile compared to ETTYF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs UNCHF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, UNCHF has a market cap of 14.4B. Regarding current trading prices, GYSN is priced at $0.00, while UNCHF trades at $8.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas UNCHF's P/E ratio is 23.46. In terms of profitability, GYSN's ROE is +0.14%, compared to UNCHF's ROE of +0.09%. Regarding short-term risk, GYSN is less volatile compared to UNCHF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs UNICY Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, UNICY has a market cap of 13.9B. Regarding current trading prices, GYSN is priced at $0.00, while UNICY trades at $3.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas UNICY's P/E ratio is 23.35. In terms of profitability, GYSN's ROE is +0.14%, compared to UNICY's ROE of +0.09%. Regarding short-term risk, GYSN is less volatile compared to UNICY. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs LCCTF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, LCCTF has a market cap of 6.6B. Regarding current trading prices, GYSN is priced at $0.00, while LCCTF trades at $4.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas LCCTF's P/E ratio is 63.57. In terms of profitability, GYSN's ROE is +0.14%, compared to LCCTF's ROE of +0.16%. Regarding short-term risk, GYSN is less volatile compared to LCCTF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs SSDOY Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, SSDOY has a market cap of 6.3B. Regarding current trading prices, GYSN is priced at $0.00, while SSDOY trades at $15.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas SSDOY's P/E ratio is -226.86. In terms of profitability, GYSN's ROE is +0.14%, compared to SSDOY's ROE of -0.03%. Regarding short-term risk, GYSN is less volatile compared to SSDOY. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs SSDOF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, SSDOF has a market cap of 6B. Regarding current trading prices, GYSN is priced at $0.00, while SSDOF trades at $15.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas SSDOF's P/E ratio is -214.29. In terms of profitability, GYSN's ROE is +0.14%, compared to SSDOF's ROE of +0.00%. Regarding short-term risk, GYSN and SSDOF have similar daily volatility (0.00).
GYSN vs KCDMF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, KCDMF has a market cap of 5.6B. Regarding current trading prices, GYSN is priced at $0.00, while KCDMF trades at $1.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas KCDMF's P/E ratio is 14.08. In terms of profitability, GYSN's ROE is +0.14%, compared to KCDMF's ROE of +1.40%. Regarding short-term risk, GYSN is less volatile compared to KCDMF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs LIOPY Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, LIOPY has a market cap of 5.4B. Regarding current trading prices, GYSN is priced at $0.00, while LIOPY trades at $19.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas LIOPY's P/E ratio is 26.49. In terms of profitability, GYSN's ROE is +0.14%, compared to LIOPY's ROE of +0.06%. Regarding short-term risk, GYSN and LIOPY have similar daily volatility (0.00).
GYSN vs KCDMY Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, KCDMY has a market cap of 5.4B. Regarding current trading prices, GYSN is priced at $0.00, while KCDMY trades at $8.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas KCDMY's P/E ratio is 14.03. In terms of profitability, GYSN's ROE is +0.14%, compared to KCDMY's ROE of +1.40%. Regarding short-term risk, GYSN is less volatile compared to KCDMY. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs BICEY Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, BICEY has a market cap of 5.3B. Regarding current trading prices, GYSN is priced at $0.00, while BICEY trades at $32.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas BICEY's P/E ratio is 11.25. In terms of profitability, GYSN's ROE is +0.14%, compared to BICEY's ROE of +0.06%. Regarding short-term risk, GYSN is less volatile compared to BICEY. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs RPHCF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, RPHCF has a market cap of 4.5B. Regarding current trading prices, GYSN is priced at $0.00, while RPHCF trades at $20.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas RPHCF's P/E ratio is 23.36. In terms of profitability, GYSN's ROE is +0.14%, compared to RPHCF's ROE of +0.03%. Regarding short-term risk, GYSN is less volatile compared to RPHCF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs UNLRF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, UNLRF has a market cap of 4.2B. Regarding current trading prices, GYSN is priced at $0.00, while UNLRF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas UNLRF's P/E ratio is 11.00. In terms of profitability, GYSN's ROE is +0.14%, compared to UNLRF's ROE of +1.07%. Regarding short-term risk, GYSN is less volatile compared to UNLRF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs UNLRY Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, UNLRY has a market cap of 4B. Regarding current trading prices, GYSN is priced at $0.00, while UNLRY trades at $2.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas UNLRY's P/E ratio is 21.10. In terms of profitability, GYSN's ROE is +0.14%, compared to UNLRY's ROE of +1.07%. Regarding short-term risk, GYSN is less volatile compared to UNLRY. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs NTCOY Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, NTCOY has a market cap of 3.8B. Regarding current trading prices, GYSN is priced at $0.00, while NTCOY trades at $5.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas NTCOY's P/E ratio is -8.30. In terms of profitability, GYSN's ROE is +0.14%, compared to NTCOY's ROE of -0.15%. Regarding short-term risk, GYSN is less volatile compared to NTCOY. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs VDAHF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, VDAHF has a market cap of 3.6B. Regarding current trading prices, GYSN is priced at $0.00, while VDAHF trades at $2.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas VDAHF's P/E ratio is 99.00. In terms of profitability, GYSN's ROE is +0.14%, compared to VDAHF's ROE of +0.03%. Regarding short-term risk, GYSN and VDAHF have similar daily volatility (0.00).
GYSN vs HEGIF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, HEGIF has a market cap of 3.3B. Regarding current trading prices, GYSN is priced at $0.00, while HEGIF trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas HEGIF's P/E ratio is 10.00. In terms of profitability, GYSN's ROE is +0.14%, compared to HEGIF's ROE of +0.14%. Regarding short-term risk, GYSN and HEGIF have similar daily volatility (0.00).
GYSN vs HEGIY Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, HEGIY has a market cap of 3.2B. Regarding current trading prices, GYSN is priced at $0.00, while HEGIY trades at $13.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas HEGIY's P/E ratio is 9.99. In terms of profitability, GYSN's ROE is +0.14%, compared to HEGIY's ROE of +0.14%. Regarding short-term risk, GYSN is less volatile compared to HEGIY. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs VDAHY Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, VDAHY has a market cap of 3B. Regarding current trading prices, GYSN is priced at $0.00, while VDAHY trades at $21.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas VDAHY's P/E ratio is 108.35. In terms of profitability, GYSN's ROE is +0.14%, compared to VDAHY's ROE of +0.02%. Regarding short-term risk, GYSN and VDAHY have similar daily volatility (0.00).
GYSN vs KBYPF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, KBYPF has a market cap of 2.8B. Regarding current trading prices, GYSN is priced at $0.00, while KBYPF trades at $37.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas KBYPF's P/E ratio is 42.06. In terms of profitability, GYSN's ROE is +0.14%, compared to KBYPF's ROE of +0.05%. Regarding short-term risk, GYSN is less volatile compared to KBYPF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs BICEF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, BICEF has a market cap of 2.7B. Regarding current trading prices, GYSN is priced at $0.00, while BICEF trades at $64.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas BICEF's P/E ratio is 11.29. In terms of profitability, GYSN's ROE is +0.14%, compared to BICEF's ROE of +0.06%. Regarding short-term risk, GYSN is less volatile compared to BICEF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs KOSCF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, KOSCF has a market cap of 2.6B. Regarding current trading prices, GYSN is priced at $0.00, while KOSCF trades at $45.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas KOSCF's P/E ratio is 62.51. In terms of profitability, GYSN's ROE is +0.14%, compared to KOSCF's ROE of +0.04%. Regarding short-term risk, GYSN and KOSCF have similar daily volatility (0.00).
GYSN vs LIOPF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, LIOPF has a market cap of 2.5B. Regarding current trading prices, GYSN is priced at $0.00, while LIOPF trades at $9.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas LIOPF's P/E ratio is 16.91. In terms of profitability, GYSN's ROE is +0.14%, compared to LIOPF's ROE of +0.06%. Regarding short-term risk, GYSN is less volatile compared to LIOPF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs BLUMY Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, BLUMY has a market cap of 2.4B. Regarding current trading prices, GYSN is priced at $0.00, while BLUMY trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas BLUMY's P/E ratio is -23.33. In terms of profitability, GYSN's ROE is +0.14%, compared to BLUMY's ROE of -0.02%. Regarding short-term risk, GYSN is less volatile compared to BLUMY. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs FACYF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, FACYF has a market cap of 2.4B. Regarding current trading prices, GYSN is priced at $0.00, while FACYF trades at $17.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas FACYF's P/E ratio is 34.22. In terms of profitability, GYSN's ROE is +0.14%, compared to FACYF's ROE of +0.09%. Regarding short-term risk, GYSN and FACYF have similar daily volatility (0.00).
GYSN vs PORBF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, PORBF has a market cap of 2.2B. Regarding current trading prices, GYSN is priced at $0.00, while PORBF trades at $9.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas PORBF's P/E ratio is 45.23. In terms of profitability, GYSN's ROE is +0.14%, compared to PORBF's ROE of +0.05%. Regarding short-term risk, GYSN is less volatile compared to PORBF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs KSRYY Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, KSRYY has a market cap of 2.1B. Regarding current trading prices, GYSN is priced at $0.00, while KSRYY trades at $7.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas KSRYY's P/E ratio is 53.79. In terms of profitability, GYSN's ROE is +0.14%, compared to KSRYY's ROE of +0.04%. Regarding short-term risk, GYSN is less volatile compared to KSRYY. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs MIOFF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, MIOFF has a market cap of 1.7B. Regarding current trading prices, GYSN is priced at $0.00, while MIOFF trades at $52.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas MIOFF's P/E ratio is 40.46. In terms of profitability, GYSN's ROE is +0.14%, compared to MIOFF's ROE of +0.08%. Regarding short-term risk, GYSN and MIOFF have similar daily volatility (0.00).
GYSN vs ONXYY Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, ONXYY has a market cap of 1.5B. Regarding current trading prices, GYSN is priced at $0.00, while ONXYY trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas ONXYY's P/E ratio is 32.86. In terms of profitability, GYSN's ROE is +0.14%, compared to ONXYY's ROE of +0.07%. Regarding short-term risk, GYSN and ONXYY have similar daily volatility (0.00).
GYSN vs PGENY Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, PGENY has a market cap of 1.5B. Regarding current trading prices, GYSN is priced at $0.00, while PGENY trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas PGENY's P/E ratio is 23.38. In terms of profitability, GYSN's ROE is +0.14%, compared to PGENY's ROE of +0.05%. Regarding short-term risk, GYSN is less volatile compared to PGENY. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs PIGEF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, PIGEF has a market cap of 1.4B. Regarding current trading prices, GYSN is priced at $0.00, while PIGEF trades at $11.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas PIGEF's P/E ratio is 23.27. In terms of profitability, GYSN's ROE is +0.14%, compared to PIGEF's ROE of +0.05%. Regarding short-term risk, GYSN is less volatile compared to PIGEF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs OLVI Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, OLVI has a market cap of 1.3B. Regarding current trading prices, GYSN is priced at $0.00, while OLVI trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas OLVI's P/E ratio is N/A. In terms of profitability, GYSN's ROE is +0.14%, compared to OLVI's ROE of -3.12%. Regarding short-term risk, GYSN and OLVI have similar daily volatility (0.00).
GYSN vs SRTSF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, SRTSF has a market cap of 890.7M. Regarding current trading prices, GYSN is priced at $0.00, while SRTSF trades at $13.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas SRTSF's P/E ratio is 17.21. In terms of profitability, GYSN's ROE is +0.14%, compared to SRTSF's ROE of +0.12%. Regarding short-term risk, GYSN is less volatile compared to SRTSF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs DUNIY Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, DUNIY has a market cap of 691.8M. Regarding current trading prices, GYSN is priced at $0.00, while DUNIY trades at $29.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas DUNIY's P/E ratio is N/A. In terms of profitability, GYSN's ROE is +0.14%, compared to DUNIY's ROE of +0.07%. Regarding short-term risk, GYSN is less volatile compared to DUNIY. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs ONXXF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, ONXXF has a market cap of 671.4M. Regarding current trading prices, GYSN is priced at $0.00, while ONXXF trades at $8.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas ONXXF's P/E ratio is 29.57. In terms of profitability, GYSN's ROE is +0.14%, compared to ONXXF's ROE of +0.06%. Regarding short-term risk, GYSN is less volatile compared to ONXXF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs MDOMF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, MDOMF has a market cap of 530.4M. Regarding current trading prices, GYSN is priced at $0.00, while MDOMF trades at $11.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas MDOMF's P/E ratio is 130.56. In terms of profitability, GYSN's ROE is +0.14%, compared to MDOMF's ROE of +0.04%. Regarding short-term risk, GYSN is less volatile compared to MDOMF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs WPNTF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, WPNTF has a market cap of 500.9M. Regarding current trading prices, GYSN is priced at $0.00, while WPNTF trades at $6.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas WPNTF's P/E ratio is 21.38. In terms of profitability, GYSN's ROE is +0.14%, compared to WPNTF's ROE of +0.49%. Regarding short-term risk, GYSN is less volatile compared to WPNTF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs PZCUY Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, PZCUY has a market cap of 479M. Regarding current trading prices, GYSN is priced at $0.00, while PZCUY trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas PZCUY's P/E ratio is -35.50. In terms of profitability, GYSN's ROE is +0.14%, compared to PZCUY's ROE of -0.22%. Regarding short-term risk, GYSN is less volatile compared to PZCUY. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs YAMNF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, YAMNF has a market cap of 464.9M. Regarding current trading prices, GYSN is priced at $0.00, while YAMNF trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas YAMNF's P/E ratio is 8.37. In terms of profitability, GYSN's ROE is +0.14%, compared to YAMNF's ROE of -0.05%. Regarding short-term risk, GYSN is less volatile compared to YAMNF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs MCBRF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, MCBRF has a market cap of 329.5M. Regarding current trading prices, GYSN is priced at $0.00, while MCBRF trades at $1.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas MCBRF's P/E ratio is 6.33. In terms of profitability, GYSN's ROE is +0.14%, compared to MCBRF's ROE of +0.50%. Regarding short-term risk, GYSN is less volatile compared to MCBRF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs UNHLF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, UNHLF has a market cap of 196.4M. Regarding current trading prices, GYSN is priced at $0.00, while UNHLF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas UNHLF's P/E ratio is 16.57. In terms of profitability, GYSN's ROE is +0.14%, compared to UNHLF's ROE of -0.01%. Regarding short-term risk, GYSN and UNHLF have similar daily volatility (0.00).
GYSN vs KITAF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, KITAF has a market cap of 130.7M. Regarding current trading prices, GYSN is priced at $0.00, while KITAF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas KITAF's P/E ratio is 15.64. In terms of profitability, GYSN's ROE is +0.14%, compared to KITAF's ROE of +0.18%. Regarding short-term risk, GYSN and KITAF have similar daily volatility (0.00).
GYSN vs NBBTF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, NBBTF has a market cap of 116.1M. Regarding current trading prices, GYSN is priced at $0.00, while NBBTF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas NBBTF's P/E ratio is -5.80. In terms of profitability, GYSN's ROE is +0.14%, compared to NBBTF's ROE of -0.07%. Regarding short-term risk, GYSN is less volatile compared to NBBTF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs RVIV Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, RVIV has a market cap of 79M. Regarding current trading prices, GYSN is priced at $0.00, while RVIV trades at $13.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas RVIV's P/E ratio is 64.29. In terms of profitability, GYSN's ROE is +0.14%, compared to RVIV's ROE of -0.08%. Regarding short-term risk, GYSN is less volatile compared to RVIV. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs KPTSF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, KPTSF has a market cap of 63.6M. Regarding current trading prices, GYSN is priced at $0.00, while KPTSF trades at $6.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas KPTSF's P/E ratio is 28.91. In terms of profitability, GYSN's ROE is +0.14%, compared to KPTSF's ROE of +0.03%. Regarding short-term risk, GYSN is less volatile compared to KPTSF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs PRFUF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, PRFUF has a market cap of 26.7M. Regarding current trading prices, GYSN is priced at $0.00, while PRFUF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas PRFUF's P/E ratio is -1.21. In terms of profitability, GYSN's ROE is +0.14%, compared to PRFUF's ROE of -0.08%. Regarding short-term risk, GYSN and PRFUF have similar daily volatility (0.00).
GYSN vs DQWS Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, DQWS has a market cap of 18.2M. Regarding current trading prices, GYSN is priced at $0.00, while DQWS trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas DQWS's P/E ratio is N/A. In terms of profitability, GYSN's ROE is +0.14%, compared to DQWS's ROE of -0.03%. Regarding short-term risk, GYSN is less volatile compared to DQWS. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs FDOGF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, FDOGF has a market cap of 10.9M. Regarding current trading prices, GYSN is priced at $0.00, while FDOGF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas FDOGF's P/E ratio is -5.00. In terms of profitability, GYSN's ROE is +0.14%, compared to FDOGF's ROE of -0.10%. Regarding short-term risk, GYSN and FDOGF have similar daily volatility (0.00).
GYSN vs PURE Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, PURE has a market cap of 8.9M. Regarding current trading prices, GYSN is priced at $0.00, while PURE trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas PURE's P/E ratio is -4.00. In terms of profitability, GYSN's ROE is +0.14%, compared to PURE's ROE of +1.13%. Regarding short-term risk, GYSN is less volatile compared to PURE. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs MIMNF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, MIMNF has a market cap of 6.8M. Regarding current trading prices, GYSN is priced at $0.00, while MIMNF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas MIMNF's P/E ratio is 17.10. In terms of profitability, GYSN's ROE is +0.14%, compared to MIMNF's ROE of N/A. Regarding short-term risk, GYSN and MIMNF have similar daily volatility (0.00).
GYSN vs SNBH Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, SNBH has a market cap of 6.5M. Regarding current trading prices, GYSN is priced at $0.00, while SNBH trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas SNBH's P/E ratio is -2.75. In terms of profitability, GYSN's ROE is +0.14%, compared to SNBH's ROE of +0.63%. Regarding short-term risk, GYSN is less volatile compared to SNBH. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs CAWW Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, CAWW has a market cap of 6.5M. Regarding current trading prices, GYSN is priced at $0.00, while CAWW trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas CAWW's P/E ratio is -5.80. In terms of profitability, GYSN's ROE is +0.14%, compared to CAWW's ROE of -0.09%. Regarding short-term risk, GYSN is less volatile compared to CAWW. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs ZOONF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, ZOONF has a market cap of 5.3M. Regarding current trading prices, GYSN is priced at $0.00, while ZOONF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas ZOONF's P/E ratio is -1.50. In terms of profitability, GYSN's ROE is +0.14%, compared to ZOONF's ROE of -1.42%. Regarding short-term risk, GYSN is less volatile compared to ZOONF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs MAVBF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, MAVBF has a market cap of 4.8M. Regarding current trading prices, GYSN is priced at $0.00, while MAVBF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas MAVBF's P/E ratio is -0.03. In terms of profitability, GYSN's ROE is +0.14%, compared to MAVBF's ROE of -2.47%. Regarding short-term risk, GYSN and MAVBF have similar daily volatility (0.00).
GYSN vs REVRQ Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, REVRQ has a market cap of 3.8M. Regarding current trading prices, GYSN is priced at $0.00, while REVRQ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas REVRQ's P/E ratio is -0.01. In terms of profitability, GYSN's ROE is +0.14%, compared to REVRQ's ROE of +0.89%. Regarding short-term risk, GYSN and REVRQ have similar daily volatility (0.00).
GYSN vs SPCO Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, SPCO has a market cap of 3.3M. Regarding current trading prices, GYSN is priced at $0.00, while SPCO trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas SPCO's P/E ratio is -10.12. In terms of profitability, GYSN's ROE is +0.14%, compared to SPCO's ROE of +0.00%. Regarding short-term risk, GYSN is less volatile compared to SPCO. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs NUVI Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, NUVI has a market cap of 3.2M. Regarding current trading prices, GYSN is priced at $0.00, while NUVI trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas NUVI's P/E ratio is N/A. In terms of profitability, GYSN's ROE is +0.14%, compared to NUVI's ROE of +9.49%. Regarding short-term risk, GYSN is less volatile compared to NUVI. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs CLGOF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, CLGOF has a market cap of 2.5M. Regarding current trading prices, GYSN is priced at $0.00, while CLGOF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas CLGOF's P/E ratio is -1.79. In terms of profitability, GYSN's ROE is +0.14%, compared to CLGOF's ROE of +1.07%. Regarding short-term risk, GYSN and CLGOF have similar daily volatility (0.00).
GYSN vs ZRVT Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, ZRVT has a market cap of 2M. Regarding current trading prices, GYSN is priced at $0.00, while ZRVT trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas ZRVT's P/E ratio is -3.00. In terms of profitability, GYSN's ROE is +0.14%, compared to ZRVT's ROE of +0.04%. Regarding short-term risk, GYSN is less volatile compared to ZRVT. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs SKVI Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, SKVI has a market cap of 1.1M. Regarding current trading prices, GYSN is priced at $0.00, while SKVI trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas SKVI's P/E ratio is -2.08. In terms of profitability, GYSN's ROE is +0.14%, compared to SKVI's ROE of +0.06%. Regarding short-term risk, GYSN is less volatile compared to SKVI. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs SLGD Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, SLGD has a market cap of 812.9K. Regarding current trading prices, GYSN is priced at $0.00, while SLGD trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas SLGD's P/E ratio is -0.19. In terms of profitability, GYSN's ROE is +0.14%, compared to SLGD's ROE of +4.57%. Regarding short-term risk, GYSN is less volatile compared to SLGD. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs NASO Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, NASO has a market cap of 688.5K. Regarding current trading prices, GYSN is priced at $0.00, while NASO trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas NASO's P/E ratio is -80.00. In terms of profitability, GYSN's ROE is +0.14%, compared to NASO's ROE of +1.48%. Regarding short-term risk, GYSN is less volatile compared to NASO. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs PYCT Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, PYCT has a market cap of 553.7K. Regarding current trading prices, GYSN is priced at $0.00, while PYCT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas PYCT's P/E ratio is N/A. In terms of profitability, GYSN's ROE is +0.14%, compared to PYCT's ROE of +0.00%. Regarding short-term risk, GYSN is less volatile compared to PYCT. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs PHLI Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, PHLI has a market cap of 438.3K. Regarding current trading prices, GYSN is priced at $0.00, while PHLI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas PHLI's P/E ratio is N/A. In terms of profitability, GYSN's ROE is +0.14%, compared to PHLI's ROE of -0.54%. Regarding short-term risk, GYSN is less volatile compared to PHLI. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs WNBD Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, WNBD has a market cap of 350K. Regarding current trading prices, GYSN is priced at $0.00, while WNBD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas WNBD's P/E ratio is N/A. In terms of profitability, GYSN's ROE is +0.14%, compared to WNBD's ROE of +0.05%. Regarding short-term risk, GYSN is less volatile compared to WNBD. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs HRSR Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, HRSR has a market cap of 185.6K. Regarding current trading prices, GYSN is priced at $0.00, while HRSR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas HRSR's P/E ratio is -0.02. In terms of profitability, GYSN's ROE is +0.14%, compared to HRSR's ROE of +65.69%. Regarding short-term risk, GYSN is less volatile compared to HRSR. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs TVOG Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, TVOG has a market cap of 105.9K. Regarding current trading prices, GYSN is priced at $0.00, while TVOG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas TVOG's P/E ratio is -0.05. In terms of profitability, GYSN's ROE is +0.14%, compared to TVOG's ROE of +0.78%. Regarding short-term risk, GYSN and TVOG have similar daily volatility (0.00).
GYSN vs EESO Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, EESO has a market cap of 72.9K. Regarding current trading prices, GYSN is priced at $0.00, while EESO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas EESO's P/E ratio is N/A. In terms of profitability, GYSN's ROE is +0.14%, compared to EESO's ROE of N/A. Regarding short-term risk, GYSN is less volatile compared to EESO. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs EOSS Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, EOSS has a market cap of 60.5K. Regarding current trading prices, GYSN is priced at $0.00, while EOSS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas EOSS's P/E ratio is -0.01. In terms of profitability, GYSN's ROE is +0.14%, compared to EOSS's ROE of +0.30%. Regarding short-term risk, GYSN is less volatile compared to EOSS. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs QNTA Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, QNTA has a market cap of 40.7K. Regarding current trading prices, GYSN is priced at $0.00, while QNTA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas QNTA's P/E ratio is 0.01. In terms of profitability, GYSN's ROE is +0.14%, compared to QNTA's ROE of +2.75%. Regarding short-term risk, GYSN and QNTA have similar daily volatility (0.00).
GYSN vs SYHO Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, SYHO has a market cap of 39.6K. Regarding current trading prices, GYSN is priced at $0.00, while SYHO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas SYHO's P/E ratio is N/A. In terms of profitability, GYSN's ROE is +0.14%, compared to SYHO's ROE of N/A. Regarding short-term risk, GYSN and SYHO have similar daily volatility (0.00).
GYSN vs GRBG Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, GRBG has a market cap of 39K. Regarding current trading prices, GYSN is priced at $0.00, while GRBG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas GRBG's P/E ratio is 0.10. In terms of profitability, GYSN's ROE is +0.14%, compared to GRBG's ROE of N/A. Regarding short-term risk, GYSN is less volatile compared to GRBG. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs BRSHF Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, BRSHF has a market cap of 33.5K. Regarding current trading prices, GYSN is priced at $0.00, while BRSHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas BRSHF's P/E ratio is N/A. In terms of profitability, GYSN's ROE is +0.14%, compared to BRSHF's ROE of +14.14%. Regarding short-term risk, GYSN is less volatile compared to BRSHF. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs JOEY Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, JOEY has a market cap of 28.2K. Regarding current trading prices, GYSN is priced at $0.00, while JOEY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas JOEY's P/E ratio is 0.01. In terms of profitability, GYSN's ROE is +0.14%, compared to JOEY's ROE of +0.00%. Regarding short-term risk, GYSN and JOEY have similar daily volatility (0.00).
GYSN vs SNST Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, SNST has a market cap of 26.6K. Regarding current trading prices, GYSN is priced at $0.00, while SNST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas SNST's P/E ratio is N/A. In terms of profitability, GYSN's ROE is +0.14%, compared to SNST's ROE of -1.59%. Regarding short-term risk, GYSN and SNST have similar daily volatility (0.00).
GYSN vs INBI Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, INBI has a market cap of 18.1K. Regarding current trading prices, GYSN is priced at $0.00, while INBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas INBI's P/E ratio is N/A. In terms of profitability, GYSN's ROE is +0.14%, compared to INBI's ROE of +0.54%. Regarding short-term risk, GYSN is less volatile compared to INBI. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs HPTN Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, HPTN has a market cap of 17.8K. Regarding current trading prices, GYSN is priced at $0.00, while HPTN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas HPTN's P/E ratio is -0.03. In terms of profitability, GYSN's ROE is +0.14%, compared to HPTN's ROE of +0.00%. Regarding short-term risk, GYSN and HPTN have similar daily volatility (0.00).
GYSN vs KPOC Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, KPOC has a market cap of 13.7K. Regarding current trading prices, GYSN is priced at $0.00, while KPOC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas KPOC's P/E ratio is N/A. In terms of profitability, GYSN's ROE is +0.14%, compared to KPOC's ROE of +0.00%. Regarding short-term risk, GYSN and KPOC have similar daily volatility (0.00).
GYSN vs NUUU Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, NUUU has a market cap of 11.8K. Regarding current trading prices, GYSN is priced at $0.00, while NUUU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas NUUU's P/E ratio is N/A. In terms of profitability, GYSN's ROE is +0.14%, compared to NUUU's ROE of +0.36%. Regarding short-term risk, GYSN is less volatile compared to NUUU. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs EMPO Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, EMPO has a market cap of 6.3K. Regarding current trading prices, GYSN is priced at $0.00, while EMPO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas EMPO's P/E ratio is N/A. In terms of profitability, GYSN's ROE is +0.14%, compared to EMPO's ROE of -0.37%. Regarding short-term risk, GYSN and EMPO have similar daily volatility (0.00).
GYSN vs BEUT Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, BEUT has a market cap of 3.2K. Regarding current trading prices, GYSN is priced at $0.00, while BEUT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas BEUT's P/E ratio is N/A. In terms of profitability, GYSN's ROE is +0.14%, compared to BEUT's ROE of +0.00%. Regarding short-term risk, GYSN and BEUT have similar daily volatility (0.00).
GYSN vs NCDP Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, NCDP has a market cap of 1.8K. Regarding current trading prices, GYSN is priced at $0.00, while NCDP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas NCDP's P/E ratio is N/A. In terms of profitability, GYSN's ROE is +0.14%, compared to NCDP's ROE of N/A. Regarding short-term risk, GYSN and NCDP have similar daily volatility (0.00).
GYSN vs MDAV Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, MDAV has a market cap of 1.4K. Regarding current trading prices, GYSN is priced at $0.00, while MDAV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas MDAV's P/E ratio is N/A. In terms of profitability, GYSN's ROE is +0.14%, compared to MDAV's ROE of -1.64%. Regarding short-term risk, GYSN is less volatile compared to MDAV. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs PCGR Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, PCGR has a market cap of 785. Regarding current trading prices, GYSN is priced at $0.00, while PCGR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas PCGR's P/E ratio is -0.01. In terms of profitability, GYSN's ROE is +0.14%, compared to PCGR's ROE of -0.18%. Regarding short-term risk, GYSN and PCGR have similar daily volatility (0.00).
GYSN vs RBCL Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, RBCL has a market cap of 221. Regarding current trading prices, GYSN is priced at $0.00, while RBCL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas RBCL's P/E ratio is N/A. In terms of profitability, GYSN's ROE is +0.14%, compared to RBCL's ROE of +0.00%. Regarding short-term risk, GYSN is less volatile compared to RBCL. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.
GYSN vs SOYO Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, SOYO has a market cap of 62. Regarding current trading prices, GYSN is priced at $0.00, while SOYO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas SOYO's P/E ratio is 0.00. In terms of profitability, GYSN's ROE is +0.14%, compared to SOYO's ROE of N/A. Regarding short-term risk, GYSN and SOYO have similar daily volatility (0.00).
GYSN vs BMXC Comparison
GYSN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GYSN stands at 14K. In comparison, BMXC has a market cap of 1. Regarding current trading prices, GYSN is priced at $0.00, while BMXC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GYSN currently has a P/E ratio of N/A, whereas BMXC's P/E ratio is -0.01. In terms of profitability, GYSN's ROE is +0.14%, compared to BMXC's ROE of +0.27%. Regarding short-term risk, GYSN is less volatile compared to BMXC. This indicates potentially lower risk in terms of short-term price fluctuations for GYSN.